“Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression
Pharmacological Research · 2024-09 · 207 · 107322
DOI: 10.1016/j.phrs.2024.107322 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2024-09. Verfasst von Yishu Yin und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Harbin Institute of Technology, Harbin 150001, China; School of Chemistry and Chemical Engineering, Harbin Institute o…. Hauptthemen laut MEDLINE: Anti-Inflammatory Agents, Inflammation, Depression, Antidepressive Agents. Die Arbeit wurde bisher 153-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Depression
Abstract (Originalsprache)
Depression is a common mental disorder, the effective treatment of which remains a challenging issue worldwide. The clinical pathogenesis of depression has been deeply explored, leading to the formulation of various pathogenic hypotheses. Among these, the monoamine neurotransmitter hypothesis holds a prominent position, yet it has significant limitations as more than one-third of patients do not respond to conventional treatments targeting monoamine transmission disturbances. Over the past few decades, a growing body of research has highlighted the link between inflammation and depression as a potential key factor in the pathophysiology of depression. In this review, we first summarize the relationship between inflammation and depression, with a focus on the pathophysiological changes mediated by inflammation in depression. The mechanisms linking inflammation to depression as well as multiple anti-inflammatory strategies are also discussed, and their efficacy and safety are assessed. This review broadens the perspective on specific aspects of using anti-inflammatory strategies for treating depression, laying the groundwork for advancing precision medicine for individuals suffering from "inflamed" depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Health, Harbin Institute of Technology, Harbin 150001, China; School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin 150001, China; National and Local Joint Engineeri…
- School of Medicine and Health, Harbin Institute of Technology, Harbin 150001, China; National and Local Joint Engineering Laboratory for Synthesis, Transformation and Separation of Extreme Environmental Nutrients, Harbi…
- China Astronaut Research and Training Center, Beijing 100094, China.
- China Astronaut Research and Training Center, Beijing 100094, China. Electronic address: liyongzhi666@sina.com.
Zitieren
APA
Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024). “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression. Pharmacological Research, 207, 107322. https://doi.org/10.1016/j.phrs.2024.107322
Vancouver
Yin Y, Ju T, Zeng D, Duan F, Zhu Y, Liu J, et al. “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression. Pharmacological Research. 2024;207:107322. doi:10.1016/j.phrs.2024.107322
BibTeX
@article{Yin2024,
author = {Yin, Yishu and Ju, Ting and Zeng, Deyong and Duan, Fangyuan and Zhu, Yuanbing and Liu, Junlian and Li, Yongzhi and Lu, Weihong},
title = {“Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression},
journal = {Pharmacological Research},
year = {2024},
volume = {207},
pages = {107322},
doi = {10.1016/j.phrs.2024.107322}
}
EUVIMED